David Stephen Geldmacher MD FACP
Dementia & Geriatrics
Director, Division of Memory Disorders and Behavioral Neurology -University of Alabama-Birmingham
Join to view full profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Geldmacher is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Director, Division of Cognitive and Behavioral Neurology
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 1987 - 1990
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1986 - 1987
SUNY Upstate Medical UniversityClass of 1986
Certifications & Licensure
NJ State Medical License 1991 - Present
AL State Medical License 2011 - 2026
VA State Medical License 2002 - 2026
OH State Medical License 1989 - 2003
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyHealth@UABMedicine, UAB Health System, 2013-2017
- CMS Meaningful Use Stage 1 Certification MyHealth@UABMedicine, UAB Health System, 2013-2017
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2013-2017
Clinical Trials
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
- Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Start of enrollment: 2015 Oct 02
- Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI Start of enrollment: 2017 Feb 01
Publications & Presentations
PubMed
- Hospitalizations and long-term care for older adults with Alzheimer's disease and related dementia: Differences across geographic regions of the United States.Giovanna Pilonieta, Maria Pisu, Roy C Martin, Liang Shan, Richard E Kennedy
Journal of Alzheimer's Disease. 2026-07-01 - A Narrative Review of Amyloid-β Monoclonal Antibodies for Alzheimer Disease: How Amyloid Species Engagement May Affect Clinical Outcomes.Richard J Caselli, David S Geldmacher, Traci B Schilling
The Neurologist. 2026-07-01 - Variations in the effect of pulse pressure on cognition based on blood pressure.Mubarick Saeed, Charles F Murchison, David S Geldmacher, Katie M Wheeler, Erik D Roberson
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 2026-07-01
Press Mentions
Clinical Trials at UAB Present Opportunity to Access Potentially Effective Anti-Alzheimer’s TherapiesJune 30th, 2025- $10 Million Endowment to UAB Will Support Parkinson’s, Alzheimer’s, Huntington’s and ALS Research and EducationApril 14th, 2025
UAB Researchers Develop New Cognitive Screening ToolMarch 14th, 2019
Grant Support
- Pioglitazone In Alzheimer'S Disease ProgressionNational Institute On Aging2002–2003
- Core--ClinicalNational Institute On Aging2000–2002
- Pioglitazone In Alzheimer'S Disease ProgressionNational Institute On Aging2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
